The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol

Pharmacology, Biochemistry, and Behavior
F L SmithS P Welch

Abstract

We have previously reported that intracerebroventricular or intrathecal administration of inactive doses of delta9-tetrahydrocannabinol (THC) greatly enhance the antinociceptive potency of morphine in the mouse tail-flick test. Experiments were conducted to test the hypothesis that morphine's potency would be enhanced in mice receiving THC and morphine by conventional per os (p.o.) and subcutaneously (s.c.) routes of administration. Antinociception was measured in the tail-flick test of radiant heat after administration of different combinations of THC and morphine p.o. and s.c. Subcutaneous administration of THC (4 and 25 mg/kg) increased the potency of s.c. morphine 8.5- and 22.3-fold, respectively, while s.c. THC (25 mg/kg) increased the potency of p.o. morphine 3.1-fold. Per os administration of THC (10 and 20 mg/kg) increased the potency of s.c. and p.o. morphine 11.4-fold and 7.6-fold, respectively. Thus, morphine's potency was significantly increased regardless of the enteral and parenteral routes of THC and morphine administration. The synthetic receptor selective cannabinoid CP-55, 940 (0.1 mg/kg, s.c.) also enhanced morphine's potency. Finally, the ability of the CB1 receptor antagonist SR141716A to antagonize the enh...Continue Reading

References

Apr 24, 1992·Brain Research·P B Smith, B R Martin
Apr 15, 1991·Biochemical Pharmacology·S NarimatsuH Yoshimura
Jan 1, 1988·Pharmacology & Therapeutics·R G Pertwee
Jan 1, 1972·Psychopharmacologia·D M Buxbaum
Aug 1, 1981·Journal of Clinical Pharmacology·M E Wall, M Perez-Reyes
Feb 1, 1995·Journal of Pain and Symptom Management·J E BealK V Shepard
Dec 1, 1994·Pharmacology, Biochemistry, and Behavior·S P Welch
Oct 1, 1993·Clinical Pharmacokinetics·Y K Tam

❮ Previous
Next ❯

Citations

Jun 21, 2005·Der Internist·L Radbruch, F Elsner
Nov 19, 2004·Der Schmerz·R RukwiedC Konrad
Nov 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rafael Maldonado, Olga Valverde
Jan 7, 2004·Life Sciences·Diana L Cichewicz
Jun 2, 2005·Pharmacology, Biochemistry, and Behavior·Daniela ViganòDaniela Parolaro
Jul 9, 2002·Brain Research. Developmental Brain Research·Eva M RomeroM Paz Viveros
Feb 13, 2001·Progress in Neurobiology·R G Pertwee
Jun 15, 1999·Progress in Neurobiology·A Ameri
Mar 4, 2000·Neuroscience Letters·J MaoD J Mayer
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·M Costigan, C J Woolf
Feb 5, 2002·Clinical Pharmacokinetics·Jorn LotschGerd Geisslinger
Aug 20, 2005·Life Sciences·Dirk G Demuth, Areles Molleman
Apr 22, 2015·The Journal of Physiological Sciences : JPS·Ahmet AltunNedim Durmus
Mar 11, 2005·Expert Opinion on Emerging Drugs·Lukas Radbruch, Frank Elsner
Dec 22, 2007·Expert Opinion on Investigational Drugs·Mellar P Davis
Jan 4, 2001·Japanese Journal of Pharmacology·T Yamamoto, K Takada
Jun 11, 2004·European Journal of Pharmacology·Melinda L Cox, Sandra P Welch
Apr 6, 2004·Clinics in Liver Disease·Nora V Bergasa
Mar 23, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Suzanne NielsenBernard Le Foll
Dec 27, 2005·European Journal of Pharmacology·John D RobertsMargaret Shih
Dec 9, 2014·Behavioural Pharmacology·Harshini NeelakantanEllen A Walker
Aug 23, 2007·Chemistry & Biodiversity·Barbara Costa
Feb 6, 2019·Pain and Therapy·Ivan UritsOmar Viswanath
Jul 15, 2009·British Journal of Pharmacology·Daniela da Fonseca PachecoIgor Dimitri Gama Duarte
Nov 16, 2005·Behavioural Pharmacology·Jay Paquette, Mary C Olmstead
Jun 21, 2019·British Journal of Pharmacology·Xiaohong ChenToby K Eisenstein
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Diana L Cichewicz, Sandra P Welch
Feb 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Diana L Cichewicz, Erin A McCarthy
Aug 5, 2017·British Journal of Pharmacology·Marek ZubrzyckiMaria Zubrzycka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.